Consun Pharmaceutical Group Schedules Key Board Meeting for Financial Approvals

Story Highlights
Consun Pharmaceutical Group Schedules Key Board Meeting for Financial Approvals

An announcement from Consun Pharmaceutical Group Ltd. ( (HK:1681) ) is now available.

Consun Pharmaceutical Group Ltd. has announced a board meeting scheduled for March 26, 2025, to discuss several key financial and operational matters. The agenda includes the approval of the audited consolidated financial statements for 2024, the draft announcement of these results, and considerations regarding a final dividend and the upcoming annual general meeting. This meeting is crucial for stakeholders as it will outline the company’s financial health and strategic decisions moving forward.

More about Consun Pharmaceutical Group Ltd.

Consun Pharmaceutical Group Ltd. is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on the production and distribution of pharmaceutical products, with a market presence on the Hong Kong Stock Exchange.

YTD Price Performance: -15.05%

Average Trading Volume: 3,943

Technical Sentiment Consensus Rating: Sell

Current Market Cap: €772.5M

See more data about 1681 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App